Search

Author/Creator Mitchel, Yale

1. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 9983 (30th May 2015)

Authors:
Kastelein, John J P; Besseling, Joost; Shah, Sukrut; Bergeron, Jean; Langslet, Gisle; Hovingh, G Kees; Al-Saady, Naab; Koeijvoets, Michiel; Hunter, John; Johnson-Levonas, Amy O; Fable, Jennifer; Sapre, Aditi; Mitchel, Yale
Journal:
Lancet
Issue:
Volume 385:Issue 9983(2015)
Page Start:
2153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes. Issue 1 (December 2016)

Authors:
Brinton, Eliot; Triscari, Joseph; Brudi, Philippe; Chen, Erluo; Johnson-Levonas, Amy; Sisk, Christine; Ruck, Rae; MacLean, Alexandra; Maccubbin, Darbie; Mitchel, Yale
Journal:
Lipids in health and disease
Issue:
Volume 15:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Lipids, Safety Parameters, and Drug Concentrations After an Additional 2 Years of Treatment With Anacetrapib in the DEFINE Study. (November 2014)

Authors:
Gotto, Antonio M.; Kher, Uma; Chatterjee, Manash Shankar; Liu, Yang; Li, Xiujiang Susie; Vaidya, Sanskruti; Cannon, Christopher P.; Brinton, Eliot A.; Moon, Jennifer E.; Shah, Sukrut; Dansky, Hayes M.; Mitchel, Yale; Barter, Philip
Journal:
Journal of cardiovascular pharmacology and therapeutics
Issue:
Volume 19:Number 6(2014:Nov.)
Page Start:
543
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗